Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)

Details for Australian Patent Application No. 2005230901 (hide)

Owner Aventis Pharmaceuticals Inc.

Inventors Rutten, Hartmut; Lim, Sungtaek; Moorcroft, Neil; Stefany, David W.; Schwahn, Uwe; Peukert, Stefan; Eastwood, Paul R.; Musick, Kwon Yon; Mehdi, Shujaath; Jiang, John Z.; Weintraub, Philip M.

Agent Watermark

Pub. Number AU-A-2005230901

PCT Pub. Number WO2005/097750

Priority 60/557,459 30.03.04 US

Filing date 29 March 2005

Wipo publication date 20 October 2005

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

C07D 213/62 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 217/24 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/097750 Priority application(s): WO2005/097750

18 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230902-Non-imidazole heterocyclic compounds as histamine H3-receptor ligands

2005230900-1-(1H-indol-1-yl)-3-(4-methylpiperazin-1 -yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (NE) and the serotonine (5-HT) activity and the monoamine reuptake for the treatment of vasomotor symptoms (VMS)